Print Page   |   Contact Us   |   Sign In   |   Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 1 of 3
1  |  2  |  3

Scientific Advancements
Wednesday, June 21, 2017   (0 Comments - view/add)
CTD Holdings Enrolls First Patient in European Phase I/II Clinical Trial of Trappsol(R) Cyclo(TM) fo »
CTD Holdings Enrolls First Patient in European Phase I/II Clinical Trial of Trappsol(R) Cyclo(TM) for Treatment of Niemann...
Wednesday, June 21, 2017   (0 Comments - view/add)
Nephure™ Obtains Self-Affirmed GRAS Notification »
June 21, 2017 10:25 AM Eastern Daylight Time Nephure™ Obtains Self-Affirmed GRAS Notification Product ex...
Tuesday, June 20, 2017   (0 Comments - view/add)
Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer »
Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer TAMPA, Fla. , June 20, 2017 /P...
Thursday, June 15, 2017   (0 Comments - view/add)
IND-Enabling Study Data Published in Human Gene Therapy Clinical Development Support Clinical Develo »
IND-Enabling Study Data Published in Human Gene Therapy Clinical Development Support Clinical Development of AGTC-402 for...
Thursday, June 15, 2017   (0 Comments - view/add)
New pathways to cancer therapy »
New pathways to cancer therapy Repurposed antifungal agent exhibits promising efficacy and safety for BCCNS treatment...
Thursday, June 8, 2017   (0 Comments - view/add)
New Zika Test Produces Results In Under An Hour »
SOURCE:  http://health.wusf.usf.edu/post/new-zika-test-produces-results-under-hour#stream/0   New Zi...
Wednesday, June 7, 2017   (0 Comments - view/add)
Aimmune Therapeutics Cuts Ribbon on Commercial Manufacturing Facility to Support Potential Launch of »
Aimmune Therapeutics Cuts Ribbon on Commercial Manufacturing Facility to Support Potential Launch of Treatment for Peanut...
Tuesday, May 30, 2017   (0 Comments - view/add)
Somahlution Announces DuraGraft Registry Initiation at Leading Cardiac Surgery Hospitals in Germany »
Somahlution Announces DuraGraft Registry Initiation at Leading Cardiac Surgery Hospitals in Germany The DuraGraf...
Tuesday, May 30, 2017   (0 Comments - view/add)
HedgePath Pharmaceuticals Announces Granting of Type-C Meeting Request by FDA and Provides Positive »
HedgePath Pharmaceuticals Announces Granting of Type-C Meeting Request by FDA and Provides Positive Clinical Trial Update...
Tuesday, May 30, 2017   (0 Comments - view/add)
HedgePath Pharmaceuticals Announces Granting of Type-C Meeting Request by FDA and Provides Positive »
HedgePath Pharmaceuticals Announces Granting of Type-C Meeting Request by FDA and Provides Positive Clinical Trial Update...
Thursday, May 25, 2017   (0 Comments - view/add)
Fruit Flies Journey to International Space Station to Study Effects of Zero Gravity on the Heart »
NEWS RELEASE Media Contacts: Susan Gammon, Ph.D. Sanford Burnham Prebys Medical Discovery Institute Office (858...
Wednesday, May 24, 2017   (0 Comments - view/add)
NovaBone Announces Irrigation Resistant Products with Carriers that have Synergistic Effect in Bone »
NovaBone Announces Irrigation Resistant Products with Carriers that have Synergistic Effect in Bone Formation May 24...
Tuesday, May 23, 2017   (0 Comments - view/add)
Exciting diabetes and obesity research highlights from Medical City »
NEWS RELEASE Media Contact: Deborah Robison Sanford Burnham Prebys Medical Discovery Institute Phone (407) 745-207...
Monday, May 22, 2017   (0 Comments - view/add)
Teewinot Life Sciences Corporation Announces New Cannabis Genome Research Program »
Teewinot Life Sciences Corporation Announces New Cannabis Genome Research Program Furthers Mission to Address Unmet Med...
Tuesday, May 16, 2017   (0 Comments - view/add)
Sanford Burnham Prebys Finds Molecule That Stops Deadly Zika from Spreading »
Sanford Burnham Prebys Finds Molecule That Stops Deadly Zika from Spreading POSTED BY   DEBBIE L. SKLAR &n...
Monday, May 15, 2017   (0 Comments - view/add)
Longeveron Announces Publication of Phase 1 Safety and Efficacy Trial Results for Allogeneic Stem Ce »
Longeveron Announces Publication of Phase 1 Safety and Efficacy Trial Results for Allogeneic Stem Cell Treatment in Frailt...
Wednesday, May 10, 2017   (0 Comments - view/add)
Longeveron Begins Enrollment of Second Cohort of Phase 1 Trial of Allogeneic Mesenchymal Stem Cells »
Longeveron Begins Enrollment of Second Cohort of Phase 1 Trial of Allogeneic Mesenchymal Stem Cells to Treat Alzheimer's D...
Tuesday, May 9, 2017   (0 Comments - view/add)
Biscayne Readies Phase 1b Trial for Novel Antiepileptic Agent BIS-001 and Receives FDA Orphan Drug D »
Biscayne Readies Phase 1b Trial for Novel Antiepileptic Agent BIS-001 and Receives FDA Orphan Drug Designation for Dravet...
Tuesday, May 9, 2017   (0 Comments - view/add)
AGTC and Collaborators Present New Data on the Natural History of X-Linked Retinoschisis (XLRS) at t »
AGTC and Collaborators Present New Data on the Natural History of X-Linked Retinoschisis (XLRS) at the Association for Res...
Wednesday, May 3, 2017   (0 Comments - view/add)
Mysterious Molecule’s Function in Skin Cancer Identified »
Mysterious Molecule’s Function in Skin Cancer Identified Non-coding RNA SPRIGHTLY plays important role in tumor growth...
Tuesday, May 2, 2017   (0 Comments - view/add)
Altor BioScience Corporation Announces FDA Fast Track Designation for Lead Candidate ALT-803 in Pati »
Altor BioScience Corporation Announces FDA Fast Track Designation for Lead Candidate ALT-803 in Patients with Non-Muscle I...
Tuesday, May 2, 2017   (0 Comments - view/add)
University of Miami Health System Starts Clinical Trial to Test Regenerative Treatment for Stroke »
University of Miami Health System Starts Clinical Trial to Test Regenerative Treatment for Stroke Pioneering study eval...
Monday, May 1, 2017   (0 Comments - view/add)
Cantex Pharmaceuticals, Inc. Announces Initiation of Phase 2 Clinical Development for CX-02 in Recur »
Cantex Pharmaceuticals, Inc. Announces Initiation of Phase 2 Clinical Development for CX-02 in Recurrent Glioblastoma...
Sunday, April 30, 2017   (0 Comments - view/add)
Friday, April 14, 2017   (0 Comments - view/add)
OBMedical Company Announces LABORVIEW® now available for Hospitals using Philips Fetal Monitoring Eq »
FOR IMMEDIATE RELEASE OBMedical Company Announces LABORVIEW® now available for Hospitals using Philips Fetal Monitor...
Tuesday, February 28, 2017   (0 Comments - view/add)
Mayo Clinic publishes genetic screen for Alzheimer's in African-Americans »
February 28, 2017   Mayo Clinic publishes genetic screen for Alzheimer's in African-Americans &nbs...
Monday, February 20, 2017   (0 Comments - view/add)
Stem Cell Company Combining Stem Cell Therapy with Hyperbaric Oxygen Treatment »
Stem Cell Company Combining Stem Cell Therapy with Hyperbaric Oxygen Treatment TAMPA, Fla. , Feb. 20, 2017 /PRNewswi...
Thursday, February 9, 2017   (0 Comments - view/add)
Prevacus to Begin Phase 1 Clinical Studies of PRV-002 for the Treatment of Concussion »
Prevacus to Begin Phase 1 Clinical Studies of PRV-002 for the Treatment of Concussion February 14, 2017 TALLAHASS...
Wednesday, February 1, 2017   (0 Comments - view/add)
Mayo Clinic to test vaccine designed to provide immune response against early breast lesions »
For additional news and information, visit: Mayo Clinic News Network ....
Tuesday, January 31, 2017   (0 Comments - view/add)
Morphogenesis Announces Issuance of US Patent for Cancer Vaccines under Expedited Cancer Moonshot Im »
Morphogenesis Announces Issuance of US Patent for Cancer Vaccines under Expedited Cancer Moonshot Immunotherapy Program...
Tuesday, January 10, 2017   (0 Comments - view/add)
TapImmune Launches Phase 2 Ovarian Cancer Trial In Platinum-Sensitive Patients »
TapImmune Launches Phase 2 Ovarian Cancer Trial In Platinum-Sensitive Patients Company-Sponsored Ovarian Cancer Trial H...
Wednesday, December 14, 2016   (0 Comments - view/add)
Natural kill cell technology to stop cancer gets licensed »
Natural kill cell technology to stop cancer gets licensed December 14, 2016 University of Centra...
Monday, December 5, 2016   (0 Comments - view/add)
TherapeuticsMD Announces Positive Top-Line Results from Pivotal Phase 3 Replenish Trial in Postmenop »
TherapeuticsMD Announces Positive Top-Line Results from Pivotal Phase 3 Replenish Trial in Postmenopausal Women with Moder...
Tuesday, November 1, 2016   (0 Comments - view/add)
TapImmune Announces Commercialization Pathway For Its HER2neu Vaccine »
TapImmune Announces Commercialization Pathway For Its HER2neu Vaccine Initiation of Company-Sponsored Phase 2 Clinical...
Thursday, October 27, 2016   (0 Comments - view/add)
Quorum Innovations Advances Human Microbiome Program »
Quorum Innovations Advances Human Microbiome Program U.S. Patent allowance for Method of identifying a biologically - a...

Displaying page 1 of 3
1  |  2  |  3

Abbott

BioFlorida, Inc. | 901 NW 35th Street | Boca Raton, FL 33431
(P) 561-653-3839 (F) 561-653-3840 admin@bioflorida.com
Membership Management Software Powered by YourMembership  ::  Legal